ahlam1399
03-15-2016, 02:05 PM
Valeant cuts 2016 revenue forecast
(Reuters) - Valeant Pharmaceuticals International Inc cut it revenue forecast for the year, due to slower growth in its U.S. dermatology, gastrointestinal and woman's health businesses.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e45a73f/sc/47/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=eAZoh9fhmdw:F7kvkcY_2BM:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=eAZoh9fhmdw:F7kvkcY_2BM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=eAZoh9fhmdw:F7kvkcY_2BM:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=eAZoh9fhmdw:F7kvkcY_2BM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=eAZoh9fhmdw:F7kvkcY_2BM:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/eAZoh9fhmdw
(Reuters) - Valeant Pharmaceuticals International Inc cut it revenue forecast for the year, due to slower growth in its U.S. dermatology, gastrointestinal and woman's health businesses.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4e45a73f/sc/47/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=eAZoh9fhmdw:F7kvkcY_2BM:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=eAZoh9fhmdw:F7kvkcY_2BM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=eAZoh9fhmdw:F7kvkcY_2BM:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=eAZoh9fhmdw:F7kvkcY_2BM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=eAZoh9fhmdw:F7kvkcY_2BM:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/eAZoh9fhmdw